Heterogenous Disease Course and Long-Term Outcome of Children's Interstitial Lung Disease Related to Filamin A Gene

Julia Carlens1, K Taneille Johnson2, Andrew Bush3,4

  • 1Clinic for Paediatric Pneumology, Allergology, and Neonatology.

Insights

Children with interstitial lung disease from FLNA variants often have severe early respiratory issues and pulmonary hypertension. While many survivors stabilize, persistent obstructive defects and PH are common, suggesting genetic testing.

Area of Science:

  • Pediatric Pulmonology
  • Genetics
  • Rare Diseases

Background:

  • Children's interstitial lung disease (chILD) associated with Filamin A (FLNA) gene variants presents with variable outcomes.
  • Understanding long-term respiratory prognosis in these children is crucial for management.

Purpose of the Study:

  • To characterize the long-term respiratory outcomes of children with FLNA variants and early-onset respiratory disease.
  • To identify factors associated with severe disease progression in this cohort.

Main Methods:

  • Retrospective analysis of longitudinal data from nine pediatric cases with FLNA variants and onset within the first 24 months of life.
  • Evaluation of clinical, radiographic, histopathologic, and cardiorespiratory data.

Main Results:

  • High rates of early respiratory support (ventilation, oxygen) and severe infective exacerbations were observed.
  • Three patients (33%) died in infancy from respiratory failure and pulmonary hypertension (PH).
  • Survivors showed decreased respiratory support needs over time but persistent moderate-to-severe obstructive defects and PH in half of the cases.

Conclusions:

  • Early mortality is a significant risk in FLNA-associated chILD, but stabilization can occur.
  • Persistent obstructive lung disease and pulmonary hypertension are common sequelae in survivors.
  • Characteristic clinical and spirometric findings warrant consideration for FLNA genetic testing in suspected cases.

Related Concept Videos

Types of Intermediate Filaments01:31

Types of Intermediate Filaments

The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
3.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
357
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
280
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
501
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K